Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of Basiliximab, With Concomitant Corticosteroids, in Steroid-Refractory Ulcerative Colitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jul 2019
Price :
$35
*
At a glance
- Drugs Basiliximab (Primary) ; Prednisone
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Cerimon Pharmaceuticals
- 28 Apr 2012 Primary endpoint 'Remission-rate' has not been met according to results published in Gastroenterology.
- 28 Apr 2012 Results published in Gastroenterology.
- 06 Oct 2009 New trial record.